Lista de obras - Maria T Voso - Dominio Público Uruguay

5-azacytidine in chronic myelomonocytic leukemia: case report and review of literature

artículo científico publicado en 2011

A Population-Based Study on Myelodysplastic Syndromes in the Lazio Region (Italy), Medical Miscoding and 11-Year Mortality Follow-Up: the Gruppo Romano-Laziale Mielodisplasie Experience of Retrospective Multicentric Registry.

artículo científico publicado en 2017

A randomized phase 2 trial of azacitidine with or without durvalumab as first-line therapy for higher-risk myelodysplastic syndromes

artículo científico publicado en 2022

A randomized phase 2 trial of azacitidine with or without durvalumab as first-line therapy for older patients with AML

artículo científico publicado en 2022

Accuracy of physician assessment of treatment preferences and health status in elderly patients with higher-risk myelodysplastic syndromes.

artículo científico publicado en 2015

Acute Promyelocytic Leukemia: Update on the Mechanisms of Leukemogenesis, Resistance and on Innovative Treatment Strategies

artículo científico publicado en 2019

Acute myeloid leukemia in elderly patients aged over 75 years: experience of a single centre.

artículo científico publicado en 2003

Adjuvant high-dose therapy with peripheral blood stem cell support for patients with high-risk breast cancer.

artículo científico publicado en 1999

An abnormal secretion of soluble mediators contributes to the hematopoietic-niche dysfunction in low-risk myelodysplastic syndrome.

artículo científico publicado en 2015

Anemia in Hodgkin's lymphoma: the role of interleukin-6 and hepcidin.

artículo científico publicado en 2010

Anemia in diffuse large B-cell non-Hodgkin lymphoma: the role of interleukin-6, hepcidin and erythropoietin.

artículo científico publicado en 2013

Atypical presentation of progressive multifocal leukoencephalopathy in a multiple myeloma patient after auto-SCT successfully treated with combination therapy

scientific article published on 01 March 2010

Autografting with CD34+ peripheral blood stem cells: retained engraftment capability and reduced tumour cell content

artículo científico publicado en 1999

Azacitidine in a patient with myelodysplastic syndrome: Impact of switching from a 5-day to the approved 7-day dosing schedule

artículo científico publicado en 2011

Blastoid mantle cell lymphoma occurring in a patient in complete remission of chronic myelogenous leukemia.

artículo científico publicado en 2007

CD68+ cell count, early evaluation with PET and plasma TARC levels predict response in Hodgkin lymphoma.

artículo científico publicado en 2016

Characteristics and outcome of therapy-related myeloid neoplasms: Report from the Italian network on secondary leukemias

artículo científico publicado en 2015

Characterization of FLT3-ITDmut acute myeloid leukemia: molecular profiling of leukemic precursor cells

artículo científico publicado en 2020

Chronic myelomonocytic leukemia treatment with azacitidine: What have we learned so far? ⬇️

artículo científico publicado el 20 de noviembre de 2012

Clinical Effects of Driver Somatic Mutations on the Outcomes of Patients With Myelodysplastic Syndromes Treated With Allogeneic Hematopoietic Stem-Cell Transplantation.

artículo científico

Clonal evolution in therapy-related neoplasms.

artículo científico publicado en 2017

Combined voriconazole plus caspofungin therapy for the treatment of probable Geotrichum pneumonia in a leukemia patient.

artículo científico publicado en 2007

Comparative analysis of azacitidine and intensive chemotherapy as front-line treatment of elderly patients with acute myeloid leukemia

artículo científico publicado en 2018

Comparative genomic analysis of PML and RARA breakpoints in paired diagnosis/relapse samples of patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy

artículo científico publicado en 2017

Comparative molecular analysis of therapy-related and de novo acute promyelocytic leukemia.

artículo científico publicado en 2011

Could haemochromatosis (HFE) gene mutations affect response to iron chelation in myelodysplastic syndrome? - Response to Lucijanic and Kusec

artículo científico publicado en 2019

Cytotoxicity and Differentiating Effect of the Poly(ADP-Ribose) Polymerase Inhibitor Olaparib in Myelodysplastic Syndromes

artículo científico publicado en 2019

Decision analysis of allogeneic hematopoietic stem cell transplantation for patients with myelodysplastic syndrome stratified according to the revised International Prognostic Scoring System

artículo científico publicado en 2017

Deferasirox chelation therapy in patients with transfusion-dependent MDS: a 'real-world' report from two regional Italian registries: Gruppo Romano Mielodisplasie and Registro Basilicata.

artículo científico publicado en 2015

Deferasirox for transfusion-dependent patients with myelodysplastic syndromes: safety, efficacy, and beyond (GIMEMA MDS0306 Trial).

artículo científico publicado en 2014

Development of a high-resolution melting curve analysis screening test for SRSF2 splicing factor gene mutations in myelodysplastic syndromes

artículo científico publicado en 2014

Differential sensitivity of leukemic and normal hematopoietic progenitors to the killing effect of hyperthermia and quercetin used in combination: role of heat-shock protein-70

scientific article published on 01 September 1997

Disappearance of spontaneous erythroid colonies in patients with myeloproliferative disorders treated by alpha-interferon

artículo científico publicado en 1992

Early and sensitive detection of PML-A216V mutation by droplet digital PCR in ATO-resistant acute promyelocytic leukemia

scientific article published on 16 January 2019

Efficacy of combined surgery and antifungal therapies for the management of invasive zygomycoses in patients with haematological malignancies.

artículo científico publicado en 2009

Eltrombopag versus placebo for low-risk myelodysplastic syndromes with thrombocytopenia (EQoL-MDS): phase 1 results of a single-blind, randomised, controlled, phase 2 superiority trial

artículo científico publicado en 2017

Endothelial progenitor cell dysfunction in myelodysplastic syndromes: possible contribution of a defective vascular niche to myelodysplasia.

artículo científico publicado en 2015

Epigenetic changes in therapy-related MDS/AML.

artículo científico publicado en 2009

Epigenetic therapy of myelodysplastic syndromes and acute myeloid leukemia.

artículo científico

Erythropoietin levels and erythroid differentiation parameters in patients with lower-risk myelodysplastic syndromes

scientific article published on 10 July 2018

Essential Thrombocythemia and Acquired von Willebrand Syndrome: The Shadowlands between Thrombosis and Bleeding

artículo científico publicado en 2020

Expression of nucleoside-metabolizing enzymes in myelodysplastic syndromes and modulation of response to azacitidine.

artículo científico publicado en 2013

Fanconi anemia gene variants in therapy-related myeloid neoplasms.

artículo científico publicado en 2015

Feasibility of allogeneic stem-cell transplantation after azacitidine bridge in higher-risk myelodysplastic syndromes and low blast count acute myeloid leukemia: results of the BMT-AZA prospective study.

artículo científico publicado en 2017

Fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in previously untreated patients with follicular non-Hodgkin lymphoma trial: a phase II non-randomised trial (FLUMIZ).

artículo científico publicado en 2008

Four doses of unpegylated versus one dose of pegylated filgrastim as supportive therapy in R-CHOP-14 for elderly patients with diffuse large B-cell lymphoma.

artículo científico publicado en 2015

GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia

artículo científico publicado en 2019

Gemtuzumab Ozogamicin Versus Best Supportive Care in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Unsuitable for Intensive Chemotherapy: Results of the Randomized Phase III EORTC-GIMEMA AML-19 Trial

artículo científico publicado en 2016

Gemtuzumab ozogamicin, cytosine arabinoside, G-CSF combination (G-AraMy) in the treatment of elderly patients with poor-prognosis acute myeloid leukemia.

artículo científico publicado en 2007

Gene expression profiling of myelodysplastic CD34+ hematopoietic stem cells treated in vitro with decitabine

article

Genetic analysis of erythrocytosis reveals possible causative and modifier gene mutations

scientific article published on 23 April 2019

Genomic analysis of therapy-related acute promyelocytic leukemias arising after malignant and non-malignant disorders

artículo científico publicado en 2014

Glutathione-S-transferase genotypes influence prognosis in follicular non-Hodgkin's Lymphoma

artículo científico publicado en 2007

Granulocyte colony-stimulating factor promotes the generation of regulatory DC through induction of IL-10 and IFN-alpha.

artículo científico publicado en 2004

High rate of remissions in chronic myelomonocytic leukemia treated with 5-azacytidine: results of an Italian retrospective study.

artículo científico publicado en 2012

High-dose ascorbate and arsenic trioxide selectively kill acute myeloid leukemia and acute promyelocytic leukemia blasts in vitro

artículo científico publicado en 2017

Identification and monitoring of atypical PML/RARA fusion transcripts in acute promyelocytic leukemia

scientific article published on 04 December 2018

Identification of a novel subpopulation of human cord blood CD34-CD133-CD7-CD45+lineage- cells capable of lymphoid/NK cell differentiation after in vitro exposure to IL-15.

artículo científico publicado en 2003

Immunomagnetic selection of CD34+ peripheral blood stem cells for autografting in patients with breast cancer

scientific article published on 01 June 1997

Impaired bactericidal and fungicidal activities of neutrophils in patients with myelodysplastic syndrome

artículo científico publicado en 2011

Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes.

artículo científico publicado en 2015

Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes

artículo científico publicado en 2020

In vivo depletion of B cells using a combination of high-dose cytosine arabinoside/mitoxantrone and rituximab for autografting in patients with non-Hodgkin's lymphoma

artículo científico publicado en 2000

Incidence and susceptibility to therapy-related myeloid neoplasms.

artículo científico publicado en 2009

Incidence of acute myeloid leukemia after breast cancer

artículo científico publicado en 2011

Increased risk of acute myeloid leukaemia due to polymorphisms in detoxification and DNA repair enzymes

scientific article published on 01 September 2007

Infection control in patients with myelodysplastic syndromes who are candidates for active treatment: Expert panel consensus-based recommendations

scientific article published on 28 October 2018

Inhibitors of DNA methylation in the treatment of hematological malignancies and MDS.

artículo científico publicado en 2003

Interleukin-6 plasma levels are modulated by a polymorphism in the NF-κB1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma.

artículo científico publicado en 2011

Involvement of central nervous system in adult patients with acute myeloid leukemia: Incidence and impact on outcome

scientific article published on 21 February 2018

Iron in Hodgkin's lymphoma.

artículo científico

Iron overload alters the energy metabolism in patients with myelodysplastic syndromes: results from the multicenter FISM BIOFER study

artículo científico publicado en 2020

Iron-chelating therapy with deferasirox in transfusion-dependent, higher risk myelodysplastic syndromes: a retrospective, multicentre study

artículo científico publicado en 2017

Long-term efficacy and toxicity results of the FLUMIZ trial (fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in untreated follicular lymphoma).

artículo científico publicado en 2012

Long-term results of all-trans retinoic acid and arsenic trioxide in non-high-risk acute promyelocytic leukemia: update of the APL0406 Italian-German randomized trial

artículo científico publicado en 2019

Longitudinal detection of DNMT3AR882H transcripts in patients with acute myeloid leukemia.

artículo científico publicado en 2018

MTHFR, TS and XRCC1 genetic variants may affect survival in patients with myelodysplastic syndromes treated with supportive care or azacitidine.

artículo científico publicado en 2017

Methylenetetrahydrofolate reductase polymorphisms in myelodysplastic syndromes and therapy-related myeloid neoplasms

artículo científico publicado en 2014

Minimal Residual Disease in Acute Myeloid Leukemia of Adults: Determination, Prognostic Impact and Clinical Applications

artículo científico publicado en 2016

Minimal residual disease as a biomarker for outcome prediction and therapy optimization in acute myeloid leukemia

artículo científico publicado en 2018

Molecular Expression of Bone Marrow Angiogenic Factors, Cell-Cell Adhesion Molecules and Matrix-Metallo-Proteinases in Plasmacellular Disorders: a Molecular Panel to İnvestigate Disease Progression

artículo científico publicado en 2018

Molecular analysis of t(15;17) genomic breakpoints in secondary acute promyelocytic leukemia arising after treatment of multiple sclerosis

artículo científico publicado en 2008

Mutational analysis of bone marrow mesenchymal stromal cells in myeloid malignancies

scientific article published on 04 May 2014

Mutational landscape of patients with acute promyelocytic leukemia at diagnosis and relapse

scientific article published on 23 July 2019

Mutational profile and haematological response to iron chelation in myelodysplastic syndromes (MDS)

artículo científico publicado en 2018

Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases.

artículo científico publicado en 2012

Myelodysplastic disorders carrying both isolated del(5q) and JAK2(V617F) mutation: concise review, with focus on lenalidomide therapy

artículo científico publicado en 2014

New treatments for myelodysplastic syndromes

artículo científico publicado en 2010

Newly proposed therapy-related myelodysplastic syndrome prognostic score predicts significant differences in overall survival and leukemia-free survival in patients treated with azacitidine.

artículo científico publicado en 2012

Nongastric marginal-zone B-cell MALT lymphoma: prognostic value of disease dissemination

artículo científico publicado en 2006

Outcome of therapy-related myeloid neoplasms treated with azacitidine

artículo científico publicado en 2012

PML-RARα kinetics and impact of FLT3-ITD mutations in newly diagnosed acute promyelocytic leukaemia treated with ATRA and ATO or ATRA and chemotherapy.

artículo científico publicado en 2016

PML/RARA inhibits expression of HSP90 and its target AKT

artículo científico publicado en 2018

PML/RARa inhibits PTEN expression in hematopoietic cells by competing with PU.1 transcriptional activity.

artículo científico publicado en 2016

Passenger lymphocyte syndrome with severe hemolytic anemia due to an anti-Jk(a) after allogeneic PBPC transplantation

artículo científico publicado en 2000

Polymorphism in cytokine genes as prognostic markers in Hodgkin's lymphoma.

artículo científico publicado en 2007

Polymorphisms of detoxification and DNA repair enzymes in myelodyplastic syndromes

artículo científico publicado en 2008

Pre-transplant persistence of minimal residual disease does not contraindicate allogeneic stem cell transplantation for adult patients with acute myeloid leukemia

artículo científico publicado en 2016

Preference for involvement in treatment decisions and request for prognostic information in newly diagnosed patients with higher-risk myelodysplastic syndromes.

artículo científico publicado en 2014

Prevalence of obesity in young adults with acute lymphoblastic leukemia

scientific article published on 01 January 1994

Primary plasma cell leukemia followed by testicular plasmacytoma

artículo científico publicado en 2011

Prolonged treatment with arsenic trioxide (ATO) and all-trans-retinoic acid (ATRA) for relapsed acute promyelocytic leukemia previously treated with ATRA and chemotherapy

artículo científico publicado en 2018

Quantification of DAPK1 promoter methylation in bone marrow and peripheral blood as a follicular lymphoma biomarker

artículo científico publicado en 2014

Rapid loss of response after withdrawal of treatment with azacitidine: a case series in patients with higher-risk myelodysplastic syndromes or chronic myelomonocytic leukemia.

artículo científico publicado en 2013

Rapid response of nodular CD30-positive mycosis fungoides to brentuximab vedotin

artículo científico publicado en 2014

Real-life experience with azacitidine in myelodysplastic syndromes according to IPSS cytogenetic profile

scientific article published on 28 February 2014

Real-life use of erythropoiesis-stimulating agents in myelodysplastic syndromes: a "Gruppo Romano Mielodisplasie (GROM)" multicenter study.

artículo científico publicado en 2016

Recombinant human erythropoietin in very elderly patients with myelodysplastic syndromes: results from a retrospective study.

artículo científico publicado en 2014

Reduced BRCA1 expression due to promoter hypermethylation in therapy-related acute myeloid leukaemia

artículo científico publicado en 2006

Response to 5-azacytidine in a patient with relapsed Hodgkin Lymphoma and a therapy-related myelodysplastic syndrome

artículo científico publicado en 2011

Revised International Prognostic Scoring System (IPSS) predicts survival and leukemic evolution of myelodysplastic syndromes significantly better than IPSS and WHO Prognostic Scoring System: validation by the Gruppo Romano Mielodisplasie Italian Reg

artículo científico publicado en 2013

Risk of acute promyelocytic leukemia in multiple sclerosis: coding variants of DNA repair genes.

artículo científico publicado en 2011

Role of BCL2L10 methylation and TET2 mutations in higher risk myelodysplastic syndromes treated with 5-Azacytidine

artículo científico publicado en 2011

SETBP1 mutations in 106 patients with therapy-related myeloid neoplasms.

artículo científico publicado en 2014

Second malignancy after treatment of adult acute myeloid leukemia: cohort study on adult patients enrolled in the GIMEMA trials

artículo científico publicado en 2004

Similarities and differences between therapy-related and elderly acute myeloid leukemia.

artículo científico publicado en 2011

Small lymphocytic lymphoma in a patient with Fabry disease.

artículo científico publicado en 2012

Somatic mutations as markers of outcome after azacitidine and allogeneic stem cell transplantation in higher-risk myelodysplastic syndromes

artículo científico publicado en 2018

Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia.

artículo científico publicado en 2015

Targeting ADP-ribosylation by PARP inhibitors in acute myeloid leukaemia and related disorders

scientific article published on 24 April 2019

The BCL2L10 Leu21Arg variant and risk of therapy-related myeloid neoplasms and de novo myelodysplastic syndromes

scientific article published on 01 November 2013

The Role of Forkhead Box Proteins in Acute Myeloid Leukemia

scientific article published on 21 June 2019

The forkhead box C1 (FOXC1) transcription factor is downregulated in acute promyelocytic leukemia.

artículo científico publicado en 2017

The poly(ADP-ribose) polymerase inhibitor olaparib induces up-regulation of death receptors in primary acute myeloid leukemia blasts by NF-κB activation

scientific article published on 08 March 2018

The small-molecule compound AC-73 targeting CD147 inhibits leukemic cell proliferation, induces autophagy and increases the chemotherapeutic sensitivity of acute myeloid leukemia cells

artículo científico publicado en 2019

The viral load of Epstein-Barr virus (EBV) DNA in peripheral blood predicts for biological and clinical characteristics in Hodgkin lymphoma.

artículo científico publicado en 2011

Therapy-related leukemia and myelodysplasia: susceptibility and incidence.

artículo científico publicado en 2007

Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification-an approach to classification of patients with t-MDS

artículo científico publicado en 2020

Therapy-related myeloid neoplasms: clinical perspectives

scientific article published on 17 September 2018

Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome after bupropion treatment for smoking cessation

artículo científico publicado en 2003

Transcriptional and Metabolic Dissection of ATRA-Induced Granulocytic Differentiation in NB4 Acute Promyelocytic Leukemia Cells

artículo científico publicado en 2020

Treatment of Low-Blast Count AML using Hypomethylating Agents

artículo científico publicado en 2017

Treatment of Philadelphia-negative myeloproliferative neoplasms in accelerated/blastic phase with azacytidine. Clinical results and identification of prognostic factors

scientific article published on 30 May 2019

Treatment of acute leukaemias with monoclonal antibodies: current status and future prospects.

artículo científico publicado en 2006

Two promoters direct expression of the murine Spi-B gene, an Ets family transcription factor ⬇️

artículo científico publicado el 30 de enero de 1998

Unraveling the mechanisms behind iron overload and ineffective hematopoiesis in myelodysplastic syndromes.

artículo científico publicado en 2017

Valproic acid at therapeutic plasma levels may increase 5-azacytidine efficacy in higher risk myelodysplastic syndromes.

artículo científico publicado en 2009

Whole blood EBV-DNA predicts outcome in diffuse large B-cell lymphoma

artículo científico publicado en 2015

Why methylation is not a marker predictive of response to hypomethylating agents.

scientific article published on April 2014

Lista de obras de Maria T Voso

5-azacytidine in chronic myelomonocytic leukemia: case report and review of literature

A Population-Based Study on Myelodysplastic Syndromes in the Lazio Region (Italy), Medical Miscoding and 11-Year Mortality Follow-Up: the Gruppo Romano-Laziale Mielodisplasie Experience of Retrospective Multicentric Registry.

A randomized phase 2 trial of azacitidine with or without durvalumab as first-line therapy for higher-risk myelodysplastic syndromes

A randomized phase 2 trial of azacitidine with or without durvalumab as first-line therapy for older patients with AML

Accuracy of physician assessment of treatment preferences and health status in elderly patients with higher-risk myelodysplastic syndromes.

Acute Promyelocytic Leukemia: Update on the Mechanisms of Leukemogenesis, Resistance and on Innovative Treatment Strategies

Acute myeloid leukemia in elderly patients aged over 75 years: experience of a single centre.

Adjuvant high-dose therapy with peripheral blood stem cell support for patients with high-risk breast cancer.

An abnormal secretion of soluble mediators contributes to the hematopoietic-niche dysfunction in low-risk myelodysplastic syndrome.

Anemia in Hodgkin's lymphoma: the role of interleukin-6 and hepcidin.

Anemia in diffuse large B-cell non-Hodgkin lymphoma: the role of interleukin-6, hepcidin and erythropoietin.

Atypical presentation of progressive multifocal leukoencephalopathy in a multiple myeloma patient after auto-SCT successfully treated with combination therapy

Autografting with CD34+ peripheral blood stem cells: retained engraftment capability and reduced tumour cell content

Azacitidine in a patient with myelodysplastic syndrome: Impact of switching from a 5-day to the approved 7-day dosing schedule

Blastoid mantle cell lymphoma occurring in a patient in complete remission of chronic myelogenous leukemia.

CD68+ cell count, early evaluation with PET and plasma TARC levels predict response in Hodgkin lymphoma.

Characteristics and outcome of therapy-related myeloid neoplasms: Report from the Italian network on secondary leukemias

Characterization of FLT3-ITDmut acute myeloid leukemia: molecular profiling of leukemic precursor cells

Chronic myelomonocytic leukemia treatment with azacitidine: What have we learned so far? ⬇️

Clinical Effects of Driver Somatic Mutations on the Outcomes of Patients With Myelodysplastic Syndromes Treated With Allogeneic Hematopoietic Stem-Cell Transplantation.

Clonal evolution in therapy-related neoplasms.

Combined voriconazole plus caspofungin therapy for the treatment of probable Geotrichum pneumonia in a leukemia patient.

Comparative analysis of azacitidine and intensive chemotherapy as front-line treatment of elderly patients with acute myeloid leukemia

Comparative genomic analysis of PML and RARA breakpoints in paired diagnosis/relapse samples of patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy

Comparative molecular analysis of therapy-related and de novo acute promyelocytic leukemia.

Could haemochromatosis (HFE) gene mutations affect response to iron chelation in myelodysplastic syndrome? - Response to Lucijanic and Kusec

Cytotoxicity and Differentiating Effect of the Poly(ADP-Ribose) Polymerase Inhibitor Olaparib in Myelodysplastic Syndromes

Decision analysis of allogeneic hematopoietic stem cell transplantation for patients with myelodysplastic syndrome stratified according to the revised International Prognostic Scoring System

Deferasirox chelation therapy in patients with transfusion-dependent MDS: a 'real-world' report from two regional Italian registries: Gruppo Romano Mielodisplasie and Registro Basilicata.

Deferasirox for transfusion-dependent patients with myelodysplastic syndromes: safety, efficacy, and beyond (GIMEMA MDS0306 Trial).

Development of a high-resolution melting curve analysis screening test for SRSF2 splicing factor gene mutations in myelodysplastic syndromes

Differential sensitivity of leukemic and normal hematopoietic progenitors to the killing effect of hyperthermia and quercetin used in combination: role of heat-shock protein-70

Disappearance of spontaneous erythroid colonies in patients with myeloproliferative disorders treated by alpha-interferon

Early and sensitive detection of PML-A216V mutation by droplet digital PCR in ATO-resistant acute promyelocytic leukemia

Efficacy of combined surgery and antifungal therapies for the management of invasive zygomycoses in patients with haematological malignancies.

Eltrombopag versus placebo for low-risk myelodysplastic syndromes with thrombocytopenia (EQoL-MDS): phase 1 results of a single-blind, randomised, controlled, phase 2 superiority trial

Endothelial progenitor cell dysfunction in myelodysplastic syndromes: possible contribution of a defective vascular niche to myelodysplasia.

Epigenetic changes in therapy-related MDS/AML.

Epigenetic therapy of myelodysplastic syndromes and acute myeloid leukemia.

Erythropoietin levels and erythroid differentiation parameters in patients with lower-risk myelodysplastic syndromes

Essential Thrombocythemia and Acquired von Willebrand Syndrome: The Shadowlands between Thrombosis and Bleeding

Expression of nucleoside-metabolizing enzymes in myelodysplastic syndromes and modulation of response to azacitidine.

Fanconi anemia gene variants in therapy-related myeloid neoplasms.

Feasibility of allogeneic stem-cell transplantation after azacitidine bridge in higher-risk myelodysplastic syndromes and low blast count acute myeloid leukemia: results of the BMT-AZA prospective study.

Fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in previously untreated patients with follicular non-Hodgkin lymphoma trial: a phase II non-randomised trial (FLUMIZ).

Four doses of unpegylated versus one dose of pegylated filgrastim as supportive therapy in R-CHOP-14 for elderly patients with diffuse large B-cell lymphoma.

GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia

Gemtuzumab Ozogamicin Versus Best Supportive Care in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Unsuitable for Intensive Chemotherapy: Results of the Randomized Phase III EORTC-GIMEMA AML-19 Trial

Gemtuzumab ozogamicin, cytosine arabinoside, G-CSF combination (G-AraMy) in the treatment of elderly patients with poor-prognosis acute myeloid leukemia.

Gene expression profiling of myelodysplastic CD34+ hematopoietic stem cells treated in vitro with decitabine

Genetic analysis of erythrocytosis reveals possible causative and modifier gene mutations

Genomic analysis of therapy-related acute promyelocytic leukemias arising after malignant and non-malignant disorders

Glutathione-S-transferase genotypes influence prognosis in follicular non-Hodgkin's Lymphoma

Granulocyte colony-stimulating factor promotes the generation of regulatory DC through induction of IL-10 and IFN-alpha.

High rate of remissions in chronic myelomonocytic leukemia treated with 5-azacytidine: results of an Italian retrospective study.

High-dose ascorbate and arsenic trioxide selectively kill acute myeloid leukemia and acute promyelocytic leukemia blasts in vitro

Identification and monitoring of atypical PML/RARA fusion transcripts in acute promyelocytic leukemia

Identification of a novel subpopulation of human cord blood CD34-CD133-CD7-CD45+lineage- cells capable of lymphoid/NK cell differentiation after in vitro exposure to IL-15.

Immunomagnetic selection of CD34+ peripheral blood stem cells for autografting in patients with breast cancer

Impaired bactericidal and fungicidal activities of neutrophils in patients with myelodysplastic syndrome

Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes.

Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes

In vivo depletion of B cells using a combination of high-dose cytosine arabinoside/mitoxantrone and rituximab for autografting in patients with non-Hodgkin's lymphoma

Incidence and susceptibility to therapy-related myeloid neoplasms.

Incidence of acute myeloid leukemia after breast cancer

Increased risk of acute myeloid leukaemia due to polymorphisms in detoxification and DNA repair enzymes

Infection control in patients with myelodysplastic syndromes who are candidates for active treatment: Expert panel consensus-based recommendations

Inhibitors of DNA methylation in the treatment of hematological malignancies and MDS.

Interleukin-6 plasma levels are modulated by a polymorphism in the NF-κB1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma.

Involvement of central nervous system in adult patients with acute myeloid leukemia: Incidence and impact on outcome

Iron in Hodgkin's lymphoma.

Iron overload alters the energy metabolism in patients with myelodysplastic syndromes: results from the multicenter FISM BIOFER study

Iron-chelating therapy with deferasirox in transfusion-dependent, higher risk myelodysplastic syndromes: a retrospective, multicentre study

Long-term efficacy and toxicity results of the FLUMIZ trial (fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in untreated follicular lymphoma).

Long-term results of all-trans retinoic acid and arsenic trioxide in non-high-risk acute promyelocytic leukemia: update of the APL0406 Italian-German randomized trial

Longitudinal detection of DNMT3AR882H transcripts in patients with acute myeloid leukemia.

MTHFR, TS and XRCC1 genetic variants may affect survival in patients with myelodysplastic syndromes treated with supportive care or azacitidine.

Methylenetetrahydrofolate reductase polymorphisms in myelodysplastic syndromes and therapy-related myeloid neoplasms

Minimal Residual Disease in Acute Myeloid Leukemia of Adults: Determination, Prognostic Impact and Clinical Applications